WQ1.F MEDAPP S.A. ZY -10

Healthcare Health Care Technology Frankfurt Exchange
0.0198 EUR
Close of Nov 12, 2026
0.0100 0.0682
Market cap
EUR 4.95M
P/E
-
P/B
2.02x
ROE
18.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is WQ1.F undervalued?

Graham number

The Graham number of MEDAPP S.A. ZY -10 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MEDAPP S.A. ZY -10 fundamental analysis

No fundamental analysis for MEDAPP S.A. ZY -10 yet.

MEDAPP S.A. ZY -10 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MEDAPP S.A. ZY -10

MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D. The company was formerly known as Yellow Hat S.A. and changed its name to MedA…

Full company profile